Anti-angiogenic peptides application in cancer therapy; a review.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Anti-angiogenic peptides application in cancer therapy; a review.
- Published In:
- Research in pharmaceutical sciences, 16(6), 559-574 (2021)
- Authors:
- Shoari, Alireza, Khodabakhsh, Farnaz, Ahangari Cohan, Reza, Salimian, Morteza, Karami, Elmira
- Database ID:
- RPEP-05759
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05759APA
Shoari, Alireza; Khodabakhsh, Farnaz; Ahangari Cohan, Reza; Salimian, Morteza; Karami, Elmira. (2021). Anti-angiogenic peptides application in cancer therapy; a review.. Research in pharmaceutical sciences, 16(6), 559-574. https://doi.org/10.4103/1735-5362.327503
MLA
Shoari, Alireza, et al. "Anti-angiogenic peptides application in cancer therapy; a review.." Research in pharmaceutical sciences, 2021. https://doi.org/10.4103/1735-5362.327503
RethinkPeptides
RethinkPeptides Research Database. "Anti-angiogenic peptides application in cancer therapy; a re..." RPEP-05759. Retrieved from https://rethinkpeptides.com/research/shoari-2021-antiangiogenic-peptides-application-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.